Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve 1. The audited financial ....
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has informed exchanges that a Board meeting is scheduled for May 26, 2026. The agenda includes consideration and approval of audited financial results for the quarter and year ended March 31, 2026. The Board will also review and recommend dividend on equity shares for FY 2025-26. The trading window for designated persons remains closed from March 16, 2026 to May 28, 2026, in compliance with SEBI insider trading regulations.
This is a routine board meeting notice and does not contain any financial results or dividend details. Shareholders should await the actual results announcement post-meeting for substantive information on performance and any dividend payout.